Last reviewed · How we verify
Klebsiella Complicated Appendicitis
Approved treatments
- Merrem · National Institutes of Health Clinical Center (CC)
- Merrem · Pfizer
Meropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Klebsiella Complicated Appendicitis patent landscape — cliff calendar, originator estates, attackable patents
- Klebsiella Complicated Appendicitis treatment landscape brief
- Klebsiella Complicated Appendicitis treatment updates RSS
Frequently asked questions about Klebsiella Complicated Appendicitis
What drugs treat Klebsiella Complicated Appendicitis?
Tracked treatments include Merrem.
What is the treatment for Klebsiella Complicated Appendicitis?
Standard treatment for Klebsiella Complicated Appendicitis includes Merrem. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Klebsiella Complicated Appendicitis patent cliff · Klebsiella Complicated Appendicitis CI report
- Treatment: Merrem · National Institutes of Health Clinical Center (CC)
- Treatment: Merrem · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing